These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 3882283

  • 1. Resistance of high and low antibody responder lines of mice to the growth of avirulent (BCG) and virulent (H37Rv) strains of mycobacteria.
    Gheorghiu M, Mouton D, Lecoeur H, Lagranderie M, Mevel JC, Biozzi G.
    Clin Exp Immunol; 1985 Jan; 59(1):177-84. PubMed ID: 3882283
    [Abstract] [Full Text] [Related]

  • 2. Mycobacterial virulence. Virulent strains of Mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity.
    North RJ, Izzo AA.
    J Exp Med; 1993 Jun 01; 177(6):1723-33. PubMed ID: 8496688
    [Abstract] [Full Text] [Related]

  • 3. Influence of the mouse Bcg, Tbc-1 and xid genes on resistance and immune responses to tuberculosis infection and efficacy of bacille Calmette-Guérin (BCG) vaccination.
    Nikonenko BV, Apt AS, Mezhlumova MB, Avdienko VG, Yeremeev VV, Moroz AM.
    Clin Exp Immunol; 1996 Apr 01; 104(1):37-43. PubMed ID: 8603530
    [Abstract] [Full Text] [Related]

  • 4. [The genetic regulation of host response to inoculation with Mycobacterium bovis (BCG) and Mycobacterium tuberculosis H37RV].
    Nikonenko BV, Mezhlumova MB, Moroz AM.
    Biull Eksp Biol Med; 1990 Nov 01; 110(11):526-8. PubMed ID: 2128037
    [Abstract] [Full Text] [Related]

  • 5. Paucibacillary tuberculosis in mice after prior aerosol immunization with Mycobacterium bovis BCG.
    Nuermberger EL, Yoshimatsu T, Tyagi S, Bishai WR, Grosset JH.
    Infect Immun; 2004 Feb 01; 72(2):1065-71. PubMed ID: 14742554
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [A study of the protective effect of the DNA vaccine encoding tubercle antigen 85B with MPT64 in mice challenged with Mycobacterium tuberculosis].
    Luo XD, Zhu DY, Chen Q, Jiang Y, Jiang S, Yang C.
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep 01; 27(9):611-6. PubMed ID: 15498274
    [Abstract] [Full Text] [Related]

  • 9. T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guérin-infected resistant and susceptible mice.
    Kramnik I, Radzioch D, Skamene E.
    Immunology; 1994 Apr 01; 81(4):618-25. PubMed ID: 8039813
    [Abstract] [Full Text] [Related]

  • 10. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
    de Lisle GW, Wards BJ, Buddle BM, Collins DM.
    Tuberculosis (Edinb); 2005 Apr 01; 85(1-2):73-9. PubMed ID: 15687030
    [Abstract] [Full Text] [Related]

  • 11. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
    Deng YH, He HY, Zhang FJ.
    Scand J Immunol; 2013 Dec 01; 78(6):497-506. PubMed ID: 24283772
    [Abstract] [Full Text] [Related]

  • 12. Mycobacterium tuberculosis H37Rv: Delta RD1 is more virulent than M. bovis bacille Calmette-Guérin in long-term murine infection.
    Sherman DR, Guinn KM, Hickey MJ, Mathur SK, Zakel KL, Smith S.
    J Infect Dis; 2004 Jul 01; 190(1):123-6. PubMed ID: 15195251
    [Abstract] [Full Text] [Related]

  • 13. [The estimation of protective efficacy of the fusion gene vaccine encoding tubercle antigen 85B and MPT64 in mice challenged with Mycobacterium tuberculosis].
    Luo XD, Zhu DY, Jiang S, Chen Q, Jiang Y.
    Zhonghua Yi Xue Za Zhi; 2004 Apr 17; 84(8):687-91. PubMed ID: 15130316
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 17; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 16. [The level and spectrum of antituberculosis antibodies in BCG-vaccinated mice and in mice and rabbits infected with a virulent mycobacterial culture].
    Markov AN, Nikonenko BV, Chernousova LN, Levi DT, Dem'ianenko NV, Litvinov VI.
    Probl Tuberk; 1993 Dec 17; (1):43-4. PubMed ID: 8327439
    [Abstract] [Full Text] [Related]

  • 17. Cellular immune response to Mycobacterium bovis (BCG) in genetically-susceptible and resistant congenic mouse strains.
    Bourassa D, Forget A, Pelletier M, Skamene E, Turcotte R.
    Clin Exp Immunol; 1985 Oct 17; 62(1):31-8. PubMed ID: 3905097
    [Abstract] [Full Text] [Related]

  • 18. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
    Kohama H, Umemura M, Okamoto Y, Yahagi A, Goga H, Harakuni T, Matsuzaki G, Arakawa T.
    Vaccine; 2008 Feb 13; 26(7):924-32. PubMed ID: 18192091
    [Abstract] [Full Text] [Related]

  • 19. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
    Mollenkopf HJ, Kursar M, Kaufmann SH.
    J Infect Dis; 2004 Aug 01; 190(3):588-97. PubMed ID: 15243936
    [Abstract] [Full Text] [Related]

  • 20. [The immunological responses induced by Mycobacterium tuberculosis heat shock protein 16.3 and its synthetic peptide in mice].
    Shi CH, Zhang TF, Zhu DS, Zhang H, Bai B, Zhao Y, Yue CL, Zhao L, Liu JL.
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Aug 01; 32(8):603-7. PubMed ID: 19958680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.